Dr. Holger Schrewe, LL.M. (London)

Hambourg Allemagne

Prix à l'honneur

Legal 500 2026

Recommended Lawyer for Private Clients for Nonprofits

For many years, Holger has been a highly regarded legal adviser for national and international companies on all questions of corporate and partnership law. His regular practice includes investments and joint ventures, including many cross-border transactions, as well as restructurings.

In addition, he supports family businesses and their owners in the organisation and implementation of business succession concepts and in asset protection. Numerous long-term client relationships are the result of his consistently structured, practical approach and experienced working methods, especially in the context of international matters.

CV

Since 2009 Partner, Taylor Wessing

2004 – 2009 Associate, Taylor Wessing

1999 – 2002 Legal clerkship, Hamburg and Melbourne

Carrière

Since 2009 Partner, Taylor Wessing

2004 – 2009 Associate, Taylor Wessing

1999 – 2002 Legal clerkship, Hamburg and Melbourne

Formation

2002 – 2004 Doctoral degree, University of Heidelberg

2002 Admitted as a lawyer, Hamburg

2002 Second state examination, Hamburg

Langues étrangères

Prix et distinctions

Legal 500 2026

Featured

The Best Lawyers™ in Germany 2025

The Best Lawyers™ in Germany 2024

JUVE Awards 2023

Experience

Représentation d'une entreprise suisse-allemande dans une procédure d'arbitrage substantielle

Représentation d'une entreprise suisse-allemande dans une procédure d'arbitrage substantielle contre une société thaïlandaise pour violation d'un accord de joint-venture. La procédure a eu lieu à Singapour et a été engagée selon les règles de la CNUDCI, administrées par la SIAC.

Dr. Holger Schrewe, LL.M. (London)

Donata Freiin von Enzberg, LL.M.

The shareholders and founders of Velox GmbH on its sale to IMCD Deutschland GmbH & Co. KG

The shareholders and founders of the chemical distributor, Velox GmbH, on the sale of 100% of their shares in Velox to IMCD Deutschland GmbH & Co. KG, a subsidiary of the Dutch company, IMCD N.V., the global leader in the sales, marketing and distribution of speciality chemicals and food ingredients. Velox, founded in 1993, is one of Europe's leading distributors of specialty raw materials for the plastics, composites, additives, caoutchouc, paints and coatings industries.

Press release

Dr. Holger Schrewe, LL.M. (London)

Robert Wethmar, LL.M. (NYU)

Dr. Philipp Behrendt, LL.M. (UNSW)

Actualités et publications récentes

View Holger's insights

Cliquer ici pour en savoir plus

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Taylor Wessing advises ]init[ shareholders on the sale of shares to EMERAM Capital Partners

21 août 2019

par plusieurs auteurs

Dr. Holger Schrewe, LL.M. (London)

Legal 500 2026

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

Legal 500 2026

The Best Lawyers™ in Germany 2025

The Best Lawyers™ in Germany 2024

JUVE Awards 2023

Experience

Représentation d'une entreprise suisse-allemande dans une procédure d'arbitrage substantielle

The shareholders and founders of Velox GmbH on its sale to IMCD Deutschland GmbH & Co. KG

Actualités et publications récentes

Taylor Wessing advises ]init[ shareholders on the sale of shares to EMERAM Capital Partners

Dr. Holger Schrewe, LL.M. (London)

Legal 500 2026

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

Legal 500 2026

The Best Lawyers™ in Germany 2025

The Best Lawyers™ in Germany 2024

JUVE Awards 2023

Experience

Représentation d'une entreprise suisse-allemande dans une procédure d'arbitrage substantielle

The shareholders and founders of Velox GmbH on its sale to IMCD Deutschland GmbH & Co. KG

Actualités et publications récentes

Taylor Wessing advises ]init[ shareholders on the sale of shares to EMERAM Capital Partners

Related news & insights

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

Proposed Amendments to the EU Medical Device Regulation

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

Impact of the new Biotech Act on Clinical Trials in the EU

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

Advising on Sona's US$45 million Series B funding

Life Sciences Legal Lens – Vol. 1

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

Hungary opens health data infrastructure for AI development

Promotional activities for medical devices may qualify as agency even without direct negotiation power

Autres avocats qui pourraient vous intéresser

Rendez-vous à